Propecia
E468960
Propecia is a brand-name prescription medication (finasteride) primarily used to treat male pattern hair loss.
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
brand-name medication
ⓘ
finasteride-containing product ⓘ prescription drug ⓘ |
| belongsToDrugClass | 5-alpha-reductase inhibitor ⓘ |
| commonSideEffect |
decreased libido
ⓘ
decreased semen volume ⓘ ejaculation disorder ⓘ erectile dysfunction ⓘ |
| contraindicatedIn | pregnant women ⓘ |
| effect |
can increase hair regrowth in some men
ⓘ
lowers scalp DHT levels ⓘ slows progression of hair loss ⓘ |
| effectOnPSA | reduces serum PSA levels ⓘ |
| effectReversesAfter | discontinuation ⓘ |
| hasActiveIngredient | finasteride ⓘ |
| hasFDAApprovalFor | treatment of male pattern hair loss in men ⓘ |
| hasGenericEquivalent | finasteride 1 mg tablets ⓘ |
| indicatedFor | adult men ⓘ |
| isAdministeredBy | oral route ⓘ |
| isDifferentFrom | Proscar NERFINISHED ⓘ |
| isFormulatedAs | oral tablet ⓘ |
| isMarketedBy | Merck & Co. NERFINISHED ⓘ |
| isProtectedBy | brand name ⓘ |
| isTaken | once daily ⓘ |
| mayAffectLabTest | prostate-specific antigen (PSA) levels ⓘ |
| mechanismOfAction |
inhibits type II 5-alpha-reductase
ⓘ
reduces conversion of testosterone to dihydrotestosterone (DHT) ⓘ |
| mustBeUsed | continuously to maintain effect ⓘ |
| notIndicatedFor |
children
ⓘ
women ⓘ |
| possibleSideEffect |
anxiety
ⓘ
depression ⓘ gynecomastia ⓘ rash ⓘ testicular pain ⓘ |
| ProscarDoseIsTypically | 5 mg finasteride daily ⓘ |
| requires | prescription ⓘ |
| requiresCautionIn |
men with liver impairment
ⓘ
men with prostate cancer risk evaluation ⓘ |
| sharesActiveIngredientWith | Proscar NERFINISHED ⓘ |
| shouldBeMonitoredBy | healthcare provider ⓘ |
| shouldNotBeHandledBy | pregnant women ⓘ |
| storageCondition | store at room temperature ⓘ |
| treats |
androgenetic alopecia in men
ⓘ
male pattern hair loss ⓘ |
| typicalDose | 1 mg finasteride once daily ⓘ |
| usedFor | long-term management of androgenetic alopecia in men ⓘ |
| warning | can cause birth defects in a male fetus if handled or ingested by pregnant women ⓘ |
| wasApprovedBy | U.S. Food and Drug Administration NERFINISHED ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.